Pathstone Family Office’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.8M | Buy |
18,985
+9,806
| +107% | +$1.96M | 0.03% | 329 |
|
|
2023
Q2 | $1.7M | Sell |
9,179
-191
| -2% | -$35.4K | 0.02% | 347 |
|
|
2023
Q1 | $1.82M | Sell |
9,370
-19,378
| -67% | -$3.77M | 0.03% | 301 |
|
|
2022
Q4 | $4M | Buy |
28,748
+851
| +3% | +$118K | 0.03% | 323 |
|
|
2022
Q3 | $4.95M | Buy |
27,897
+18,605
| +200% | +$3.3M | 0.04% | 235 |
|
|
2022
Q2 | $1.9M | Buy |
9,292
+1,126
| +14% | +$230K | 0.04% | 224 |
|
|
2022
Q1 | $1.95M | Sell |
8,166
-885
| -10% | -$211K | 0.05% | 177 |
|
|
2021
Q4 | $2.09M | Buy |
9,051
+3,224
| +55% | +$745K | 0.05% | 184 |
|
|
2021
Q3 | $1.13M | Sell |
5,827
-720
| -11% | -$139K | 0.03% | 263 |
|
|
2021
Q2 | $1.39M | Buy |
6,547
+2,534
| +63% | +$539K | 0.04% | 205 |
|
|
2021
Q1 | $819K | Buy |
4,013
+3,659
| +1,034% | +$747K | 0.03% | 248 |
|
|
2020
Q4 | $65K | Buy |
354
+223
| +170% | +$40.9K | ﹤0.01% | 465 |
|
|
2020
Q3 | $22K | Hold |
131
| – | – | ﹤0.01% | 460 |
|
|
2020
Q2 | $21K | Hold |
131
| – | – | ﹤0.01% | 417 |
|
|
2020
Q1 | $22K | Sell |
131
-10
| -7% | -$1.68K | ﹤0.01% | 406 |
|
|
2019
Q4 | $283K | Buy |
141
+12
| +9% | +$24.1K | ﹤0.01% | 366 |
|
|
2019
Q3 | $27K | Hold |
129
| – | – | ﹤0.01% | 356 |
|
|
2019
Q2 | $25K | Sell |
129
-77
| -37% | -$14.9K | ﹤0.01% | 416 |
|
|
2019
Q1 | $34K | Buy |
206
+91
| +79% | +$15K | ﹤0.01% | 354 |
|
|
2018
Q4 | $21K | Buy |
+115
| New | +$21K | 0.01% | 260 |
|
|
2017
Q2 | – | Sell |
-14
| Closed | -$2K | – | 432 |
|
|
2017
Q1 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 375 |
|